Clinical Trial

Virtual Reality Assisted Schema Therapy

Study acronym: VRAST
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Schema therapy helps people understand which emotional needs were not met during childhood, and how they can take care of those needs now. One important part of the therapy is the chairwork exercise, where people imagine talking to different parts of themselves (like the strict parent or the hurt child) using empty chairs. These exercises can be very helpful, but they can also be difficult for people who find it hard to imagine things in their mind. Virtual Reality (VR) can make these exercises easier and more powerful. VR creates a 3D world that feels real, using special equipment like a headset. In this world, people can see and interact with virtual characters that represent different parts of themselves. This can make the therapy more concrete and easier to understand, especially for people who struggle with imagination. In this study, the investigators want to compare the regular imagination-based exercise with the chairwork exercise done in Virtual Reality. Everyone who joins the study will do both versions of the exercise-one with imagination and one with VR. The order will be random. Before and after each exercise, a short assessment will be conducted to see how people feel. At the end, there will also be a short interview about their experience. The whole session will take about 1.5 to 2 hours. The investigators want to know if people experience the VR exercise differently than the regular imagination exercise. The investigators also want to know if these differences depend on how well someone can imagine things in their mind.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-08.
Status change: Not Yet Recruiting → Recruiting 2026-05-11
Trial Details
NCT Number NCT07171736
Lead Sponsor University Medical Center Groningen
Collaborators: University of Groningen
Conditions Healthy Participants
Enrollment 30 participants
Start Date 2026-01-29
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-15